2 results
Approved WMOWill not start
Primary ObjectiveTo evaluate the preliminary safety and tolerability and the preliminary efficacy of cobimetinib administered as single agent (Arm A), cobimetinib + venetoclax (Arm B), and cobimetinib + venetoclax + atezolizumab (Arm C)Secondary…
Approved WMOWill not start
The objective of this study is to assess the safety and feasibility of the Doraya Catheter in the treatment of subjects hospitalized with congestive AHF, with insufficient response to diuretic therapy.